The stock of niche financial software company Vertex ( VERX 4.13%) didn't get a very good start to the trading week at all.
Advocacy groups form a buyer’s club to obtain generic versions of pricey Vertex cystic fibrosis drug
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
People don't like online forms (gasp!). And it's not hard to see why: Online forms require extra work (and time) and typically stand in the way of a consumer's getting what he or she really wants—such ...
A weather system in the Caribbean is likely to become a tropical storm later this week, according to meteorologists. The United States’ National Hurricane Center has increased the chances of a ...
Shares of semiconductor testing company FormFactor (NASDAQ:FORM) fell 4.9% in the afternoon session after the semiconductor sector sold off after peer Texas Instruments provided a cautious forecast.
Shares of semiconductor testing company FormFactor (NASDAQ:FORM) jumped 2.7% in the afternoon session after the company's stock rose along with others in the semiconductor sector after industry giant ...
According to a new report, Samsung is giving up on ultra-thin phones anhd has canceled the Galaxy S26 Edge after seeing how big of a failure the Galaxy S25 Edge has been. NewsPim reports out of Korea ...
FormFactor (NASDAQ:FORM) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The following table encapsulates their recent ...
Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. Amy is an ACA and the CEO and founder of ...
Hosted on MSN
FormFactor (FORM) Q3 Earnings: What To Expect
Semiconductor testing company FormFactor (NASDAQ:FORM) will be reporting earnings this Wednesday after market hours. Here’s what to expect. FormFactor beat analysts’ revenue expectations by 3.4% last ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results